{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:47:53Z","timestamp":1782326873433,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Mild traumatic brain injuries (mTBI) affect millions of people worldwide every year as one of the most common clinical presentations in the emergency department. Diagnosis is mainly based on clinical criteria and computed tomography scans. The use of computed tomography causes high costs, long waiting times in daily clinical practice and radiation exposure. GFAP (glial fibrillary acidic protein) and UCH-L1 (ubiquitin carboxyl-terminal hydrolase-L1) turned out to be potential biomarkers for the diagnosis of mTBI. This study retrospectively evaluates the possible use of these biomarkers combined as negative predictors for excluding brain injuries in patients with suspected mTBI in the emergency department.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adult patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009320) registered in the emergency department at a level 1 trauma emergency center in Germany (Cologne Merheim Medical Center\/CMMC) between 11\/2023 and 04\/2024, with suspected mTBI, Glasgow Coma Scale (GCS) score 13\u201315 and within 12\u00a0h after trauma were considered. All evaluable patients underwent cranial CT (cCT) scans and blood tests for GFAP and UCH-L1 serum concentrations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Biomarkers GFAP and UCH-L1 were tested positive in 261 patients (82%) while CT detected intracranial injuries in only 29 patients (9%). Biomarkers combined had a sensitivity of 97% and a negative predictive value (NPV) of 98% in mTBI diagnosis with a negative CT scan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The biomarkers GFAP and UCH-L1 combined could play a potential clinical role in avoiding unnecessary cCT scans in emergency departments after mTBI, might reduce treatment times and reduce radiation exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-026-03244-y","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:44:23Z","timestamp":1782279863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-based biomarkers GFAP\/UCH-L1 for the diagnosis of mild traumatic brain injury (mTBI): a single-center implementation experience"],"prefix":"10.1007","volume":"52","author":[{"given":"Marc","family":"Maegele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Breidenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"Keles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schroeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"11","key":"3244_CR1","doi-asserted-by":"publisher","first-page":"P1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas AIR, Menon DK, Manely GT, et al. Traumatic brain injury: Progress and challenges in prevention, clinical care and research. Lancet Neurol. 2022;21(11):P1004\u20131060.","journal-title":"Lancet Neurol"},{"key":"3244_CR2","first-page":"1","volume":"33","author":"A Brazinova","year":"2016","unstructured":"Brazinova A, Rehorcikova V, Taylor M, et al. Epidemiology of traumatic brain injury in Europe: A living systematic review. J Neurotrauma. 2016;33:1\u201330.","journal-title":"J Neurotrauma"},{"key":"3244_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/HTR.0000000000000187","volume":"31","author":"FK Korley","year":"2016","unstructured":"Korley FK, Kelen GD, Jones CM, Dias-Arrastia R. Emergency department evaluation of traumatic brain injury in the United States, 2009\u20132010. J Head Trauma Rehabil. 2016;31:379\u201387.","journal-title":"J Head Trauma Rehabil"},{"issue":"1","key":"3244_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13244-020-00925-z","volume":"11","author":"RJM Bruls","year":"2020","unstructured":"Bruls RJM, Kwee RM. Workload for radiologists during on-call hours: Dramatic increase in the past 15 years. Insights Imaging. 2020;11(1):121.","journal-title":"Insights Imaging"},{"key":"3244_CR5","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.bas.2023.102735","volume":"4","author":"I Hossain","year":"2024","unstructured":"Hossain I, Marklund N, Czeiter E, Hutchinson P, B\u00fcki A. Blood biomarkers for traumatic brain injury: A narrative review of current evidence. Brain Spine. 2024;4:102735.","journal-title":"Brain Spine"},{"key":"3244_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nicl.2013.12.009","volume":"4","author":"C Eierud","year":"2014","unstructured":"Eierud C, Craddock RC, Fletcher M, et al. Neuroimaging after mild traumatic brain injury: Review and meta-analysis. Neuroimage: Clin. 2014;4:283\u201394.","journal-title":"Neuroimage: Clin"},{"issue":"24","key":"3244_CR7","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1089\/neu.2020.7081","volume":"37","author":"M Mohammadian","year":"2020","unstructured":"Mohammadian M, Roine T, Hirvonen J, et al. Alterations in microstructure and local fiber orientation of white matter are associated with outcome after mild traumatic brain injury. J Neurotrauma. 2020;37(24):2616\u201323.","journal-title":"J Neurotrauma"},{"issue":"1","key":"3244_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1741-7015-11-50","volume":"11","author":"J Unden","year":"2013","unstructured":"Unden J, et al. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: An evidence and consensus-based update. BMC Med. 2013;11(1):50. Practice Guideline ResearchSupport, Non-U.S.","journal-title":"BMC Med"},{"issue":"4","key":"3244_CR9","first-page":"101260","volume":"42","author":"C Gil-Jardin\u00e9","year":"2023","unstructured":"Gil-Jardin\u00e9 C, et al. Management of patients suffering from mild traumatic brain injury 2023. Anaesth Crit Care Pain Med. 2023;42(4):101260.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"3244_CR10","first-page":"31","volume":"3","author":"RF Temboury","year":"2024","unstructured":"Temboury RF, et al. Mild head trauma and biomarkers of acute brain injury. Rev Esp Urg Emerg. 2024;3:31\u20136.","journal-title":"Rev Esp Urg Emerg"},{"issue":"13\u201314","key":"3244_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1089\/neu.2024.0581","volume":"42","author":"JJ Bazarian","year":"2025","unstructured":"Bazarian JJ, et al. Blood-based biomarkers for improved characterization of traumatic brain injury: Recommendations from the 2024 National Institute for Neurological Disorders and Stroke traumatic brain injury classification and nomenclature initiative blood-based biomarkers working group. J Neurotrauma. 2025;42(13\u201314):1065\u201385.","journal-title":"J Neurotrauma"},{"issue":"9","key":"3244_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): A multicentre observational study. Lancet Neurol. 2018;17(9):782\u20139.","journal-title":"Lancet Neurol"},{"issue":"10","key":"3244_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S1474-4422(19)30282-0","volume":"18","author":"JK Yue","year":"2019","unstructured":"Yue JK, Yuh EL, Korley FK, et al. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: A prospective multicentre study. Lancet Neurol. 2019;18(10):953\u201361.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3244_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0006-8993(71)90668-8","volume":"28","author":"LF Eng","year":"1971","unstructured":"Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971;28(2):351\u20134.","journal-title":"Brain Res"},{"issue":"11","key":"3244_CR15","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/neu.2016.4772","volume":"34","author":"RD Welch","year":"2017","unstructured":"Welch RD, Ellis M, Lewis LM, et al. Modeling the kinetics of serum glial fibrillary acid protein, ubiquitin carboxyl-terminal-hydrolase-L1, and S100B concentrations in patients with traumatic brain injury. J Neurotrauma. 2017;34(11):1957\u201371.","journal-title":"J Neurotrauma"},{"key":"3244_CR16","doi-asserted-by":"crossref","unstructured":"Thelin EP, Zeiler FA, Ercole A, Mondello S, B\u00fcki A, Bellander BM, et al. Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol. 2017;8:300.","DOI":"10.3389\/fneur.2017.00300"},{"issue":"3","key":"3244_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3244_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","volume":"111","author":"Y Liu","year":"2002","unstructured":"Liu Y, Fallon I, Lashuel HA, et al. The UCH-L1 gene encodes two opposing enzymatic activities that affect \u03b1-synuclein degradation and Parkinson\u00b4s disease susceptibility. Cell. 2002;111(2):209\u201318.","journal-title":"Cell"},{"issue":"5","key":"3244_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","volume":"73","author":"L Papa","year":"2016","unstructured":"Papa L, Brophy GM, Welch RD, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73(5):551\u201360.","journal-title":"JAMA Neurol"},{"issue":"1","key":"3244_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KKW, Papa I, et al. Acute biomarkers of traumatic brain injury: Relationship between plasma levels of ubiquitin C-terminal hydrolase and glial fibrillary acidic protein. J Neurotrauma. 2014;31(1):19\u201325.","journal-title":"J Neurotrauma"},{"key":"3244_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajem.2024.12.005","volume":"89","author":"RD Welch","year":"2025","unstructured":"Welch RD, Bazarian JJ, Chen JY, et al. A high-performance core laboratory GFAP\/UCH-L1 test for the prediction of intracranial injury after mild traumatic brain injury. Am J Emerg Med. 2025;89:129\u201334.","journal-title":"Am J Emerg Med"},{"issue":"11","key":"3244_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/acem.14366","volume":"28","author":"JJ Bazarian","year":"2021","unstructured":"Bazarian JJ, Welch RD, Caudle K, et al. Accuracy of a rapid glial fibrillary acidic protein\/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury. Acad Emerg Med. 2021;28(11):1308\u201317.","journal-title":"Acad Emerg Med"},{"issue":"23","key":"3244_CR23","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1089\/neu.2020.7140","volume":"37","author":"DO Okonkwo","year":"2020","unstructured":"Okonkwo DO, Puffer RC, Puccio AM, et al. Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: A transforming research and clinical knowledge in traumatic brain injury study. J Neurotrauma. 2020;37(23):2460\u20137.","journal-title":"J Neurotrauma"},{"key":"3244_CR24","doi-asserted-by":"publisher","first-page":"102785","DOI":"10.1016\/j.ebiom.2020.102785","volume":"56","author":"E Czeiter","year":"2020","unstructured":"Czeiter E, Amrein K, Gravesteijn BY, et al. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56:102785.","journal-title":"EBioMedicine"},{"issue":"14","key":"3244_CR25","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1089\/neu.2018.6254","volume":"36","author":"JP Posti","year":"2019","unstructured":"Posti JP, Takala RSK, Lagerstedt L, et al. Correlation of blood biomarkers and biomarker panels with traumatic findings on computed tomography after traumatic brain injury. J Neurotrauma. 2019;36(14):2178\u201389.","journal-title":"J Neurotrauma"},{"issue":"1","key":"3244_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12883-016-0723-z","volume":"16","author":"O Calcagnile","year":"2016","unstructured":"Calcagnile O, Anell A, Unden J. The addition of 100B to guidelines for management of mild head injuries is potentially cost saving. BMC Neurol. 2016;16(1):200.","journal-title":"BMC Neurol"},{"issue":"29","key":"3244_CR27","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1089\/neu.2018.6351","volume":"36","author":"M Minkkinen","year":"2019","unstructured":"Minkkinen M, Iverson GI, Kotilainen AK, et al. Prospective validation of the Scandinavian guidelines for initial management of minimal, mild, and moderate head injuries in adults. J Neurotrauma. 2019;36(29):2904\u201312.","journal-title":"J Neurotrauma"},{"key":"3244_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12245-024-00708-z","volume":"17","author":"J Legramante","year":"2024","unstructured":"Legramante J, Minieri M, Belli M, et al. Evaluation of GFAP\/UCH-L1 biomarkers for computed tomography exclusion in mild traumatic brain injury (mTBI). Intern J Emerg Med. 2024;17:164.","journal-title":"Intern J Emerg Med"},{"key":"3244_CR29","doi-asserted-by":"publisher","unstructured":"Campagna D, Cucuzza F, Martines GF, Amico L, Mirabella F, Privitera E, et al. The role of two brain injury biomarkers, GFAP and UCH-L1, for the management of mTBI in the emergency department: an observational study. Intern Emerg Med. 2025 Jun 4. https:\/\/doi.org\/10.1007\/s11739-025-04000-7","DOI":"10.1007\/s11739-025-04000-7"},{"issue":"13\u201314","key":"3244_CR30","first-page":"e1630","volume":"41","author":"W Chayoua","year":"2024","unstructured":"Chayoua W, Visser K, de Koning ME, et al. Evaluation of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 using rapid point of care test for predicting head computed tomography lesions after mild traumatic brain injury in a Dutch multi-center cohort study. J Neurotrauma. 2024;41(13\u201314):e1630\u20131640.","journal-title":"J Neurotrauma"},{"key":"3244_CR31","doi-asserted-by":"publisher","unstructured":"Lagares A, de la Cruz J, Terisse H, Majdan M, Vieira M, Lecky F, et al. An automated blood test for Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to predict the absence of intracranial lesions on head CT in adult patients with mild traumatic brain injury: BRAINI, a multicentre observational study in Europe. EBioMedicine. 2024 Dec;110:105477. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105477","DOI":"10.1016\/j.ebiom.2024.105477"},{"issue":"20","key":"3244_CR32","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1089\/neu.2018.5694","volume":"35","author":"RC Gardner","year":"2018","unstructured":"Gardner RC, Rubenstein R, Wang KKW, et al. Age-related differences in diagnostic accuracy of plasma glial fibrillary acidic protein and tau for identifying acute intracranial trauma on computed tomography: A TRACK TBI study. J Neurotrauma. 2018;35(20):2341\u201350.","journal-title":"J Neurotrauma"},{"key":"3244_CR33","first-page":"91","volume":"05","author":"MD Ward","year":"2020","unstructured":"Ward MD, Weber A, Merrill VD, et al. Predictive performance of traumatic brain injury biomarkers in high-risk elderly patients. JALM. 2020;05:01: 91\u2013100.","journal-title":"JALM"},{"issue":"1","key":"3244_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-200755","volume":"78","author":"BM Asken","year":"2020","unstructured":"Asken BM, Elahi FM, La Joie R, et al. Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage. J Alzheimers Dis. 2020;78(1):265\u201376.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3244_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1017\/S1355617721000813","volume":"28","author":"BM Asken","year":"2022","unstructured":"Asken BM, VandeVrede L, Rojas JC, et al. Lower white matter volume and worse executive functioning reflected in higher levels of plasma GFAP among older adults with and without cognitive impairment. J Int Neuropsychol Soc. 2022;28(6):588\u201399.","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"3244_CR36","doi-asserted-by":"publisher","first-page":"fcac316","DOI":"10.1093\/braincomms\/fcac316","volume":"5","author":"RC Gardner","year":"2023","unstructured":"Gardner RC, Puccio AM, Korley FK, et al. Effects of age and time since injury on traumatic brain injury blood biomarkers: A TRACK-TBI Study. Brain Commun. 2023;5(1):fcac316.","journal-title":"Brain Commun"},{"issue":"9696","key":"3244_CR37","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(09)61558-0","volume":"374","author":"N Kuppermann","year":"2009","unstructured":"Kuppermann N, Holmes JF, Dayan PS, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: A prospective cohort study. Lancet. 2009;374(9696):1160\u201370.","journal-title":"Lancet"},{"issue":"5","key":"3244_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/archdischild-2013-305004","volume":"99","author":"D Schonfeld","year":"2014","unstructured":"Schonfeld D, Bressan S, Da Dalt L, Henien MN, Winnett JA, Nigrovic LE. Pediatric Emergency Care Applied Research Network head injury clinical prediction rules are reliable in practice. Arch Dis Child. 2014;99(5):427\u201331.","journal-title":"Arch Dis Child"},{"key":"3244_CR39","doi-asserted-by":"publisher","first-page":"28203","DOI":"10.1038\/srep28203","volume":"6","author":"S Mondello","year":"2016","unstructured":"Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP. Serum concentrations of ubiquitin c-terminal hydrolase-L1 and glial fibrillary acidic protein after pediatric traumatic brain injury. Sci Rep. 2016;6:28203.","journal-title":"Sci Rep"},{"key":"3244_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12916-015-0533-y","volume":"13","author":"L Unden","year":"2015","unstructured":"Unden L, Calcagnile O, Unden J, et al. Validation of the Scandinavian guidelines for initial management of minimal, mild, and moderate traumatic brain injury in adults. BMC Med. 2015;13:292.","journal-title":"BMC Med"},{"issue":"2","key":"3244_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","volume":"159","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Nelson DW, Bellander BM. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir. 2017;159(2):209\u201325.","journal-title":"Acta Neurochir"},{"issue":"22","key":"3244_CR42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1089\/neu.2013.3245","volume":"31","author":"L Papa","year":"2014","unstructured":"Papa L, Silvestri S, Brophy GM, et al. GFAP out-performs S100B in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotrauma. 2014;31(22):1815\u201322.","journal-title":"J Neurotrauma"},{"key":"3244_CR43","doi-asserted-by":"crossref","unstructured":"Puravet A, Oris C, Pereira B, Couvy-Duchesne B, Mrozek S, Sapin V, et al. Can the association of biomarkers GFAP and UCH-L1 predict intracranial injury after mild traumatic brain injury in adults? A systematic review and meta-analysis. Ann Emerg Med. 2025. In press.","DOI":"10.1016\/j.annemergmed.2025.03.018"},{"key":"3244_CR44","doi-asserted-by":"crossref","unstructured":"Karamian A, Farzaneh H, Khoshnoodi M, Niazkar HR, Ghaffarzad A, Shahriari M, et al. Accuracy of GFAP and UCH-L1 in predicting brain abnormalities on CT scans after mild traumatic brain injury: a systematic review and meta-analysis. Eur J Trauma Emerg Surg. 2025;51(1):68.","DOI":"10.1007\/s00068-024-02697-3"},{"key":"3244_CR45","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1134\/S1062359023110146","volume":"50","author":"MB Moseeva","year":"2023","unstructured":"Moseeva MB. The effect of ionizing radiation on the development of tumors in the central nervous system. Biology Bull. 2023;50:2962\u201370.","journal-title":"Biology Bull"},{"issue":"1","key":"3244_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1470-2045(22)00655-6","volume":"24","author":"M Hauptmann","year":"2013","unstructured":"Hauptmann M, Byrnes G, Cardis E, Bernier MO, Blettner M, Dabin J, et al. Brain cancer after radiation exposure from CT examinations of children and young adults: Results from the EPI-CT cohort study. Lancet Oncol. 2013;24(1):45\u201353.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3244_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","volume":"18","author":"KKL Wang","year":"2018","unstructured":"Wang KKL, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18(2):165\u201380.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-026-03244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-026-03244-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-026-03244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:02:47Z","timestamp":1782324167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-026-03244-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1007\/s00068-026-03244-y","relation":{},"ISSN":["1863-9941"],"issn-type":[{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was appoved by the Ethics Committee of Witten\/Herdecke University (S-180\/2024) and conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki. Since this involved a retrospective analysis of routinely collected data as part of a process implementation, no separate informed consent from patients was required. There was no funding to this work except for the reagants for the biomarker assays which were provided by Abbott Inc (USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}